Aehr Test Systems Stock EBITDA
| AEHR Stock | USD 12.18 0.91 8.07% |
Aehr Test Systems fundamentals help investors to digest information that contributes to Aehr Test's financial success or failures. It also enables traders to predict the movement of Aehr Stock. The fundamental analysis module provides a way to measure Aehr Test's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aehr Test stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 11.4 M | 12 M |
Aehr | EBITDA |
Aehr Test Systems Company EBITDA Analysis
Aehr Test's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Aehr Test EBITDA | 11.44 M |
Most of Aehr Test's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aehr Test Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aehr EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Aehr Test is extremely important. It helps to project a fair market value of Aehr Stock properly, considering its historical fundamentals such as EBITDA. Since Aehr Test's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aehr Test's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aehr Test's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Aehr Ebitda
Ebitda |
|
According to the company disclosure, Aehr Test Systems reported earnings before interest,tax, depreciation and amortization of 11.44 M. This is 98.76% lower than that of the Semiconductors & Semiconductor Equipment sector and 98.34% lower than that of the Information Technology industry. The ebitda for all United States stocks is 99.71% higher than that of the company.
Aehr EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aehr Test's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aehr Test could also be used in its relative valuation, which is a method of valuing Aehr Test by comparing valuation metrics of similar companies.Aehr Test is currently under evaluation in ebitda category among its peers.
Aehr Test ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aehr Test's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aehr Test's managers, analysts, and investors.Environmental | Governance | Social |
Aehr Test Institutional Holders
Institutional Holdings refers to the ownership stake in Aehr Test that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aehr Test's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aehr Test's value.| Shares | Oberweis Asset Management Inc | 2024-06-30 | 534.4 K | Federated Hermes Inc | 2024-09-30 | 413.3 K | Pier Capital, Llc | 2024-09-30 | 412.1 K | Rice Hall James & Associates, Llc | 2024-09-30 | 398.8 K | Ameriprise Financial Inc | 2024-06-30 | 384.7 K | Citadel Advisors Llc | 2024-06-30 | 352.1 K | Two Sigma Investments Llc | 2024-06-30 | 334.6 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 316.9 K | Wellington Management Company Llp | 2024-06-30 | 302.3 K | Fmr Inc | 2024-09-30 | 2.6 M | Vanguard Group Inc | 2024-09-30 | 2.1 M |
Aehr Fundamentals
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.0305 | ||||
| Profit Margin | 0.50 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 302.81 M | ||||
| Shares Outstanding | 29.63 M | ||||
| Shares Owned By Insiders | 5.88 % | ||||
| Shares Owned By Institutions | 77.41 % | ||||
| Number Of Shares Shorted | 6.25 M | ||||
| Price To Earning | 70.48 X | ||||
| Price To Book | 2.73 X | ||||
| Price To Sales | 5.90 X | ||||
| Revenue | 66.22 M | ||||
| Gross Profit | 23.66 M | ||||
| EBITDA | 11.44 M | ||||
| Net Income | 33.16 M | ||||
| Cash And Equivalents | 30.05 M | ||||
| Cash Per Share | 1.32 X | ||||
| Total Debt | 6.2 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 5.99 X | ||||
| Book Value Per Share | 4.14 X | ||||
| Cash Flow From Operations | 1.76 M | ||||
| Short Ratio | 3.81 X | ||||
| Earnings Per Share | 0.98 X | ||||
| Price To Earnings To Growth | 5.92 X | ||||
| Target Price | 25.0 | ||||
| Number Of Employees | 115 | ||||
| Beta | 2.04 | ||||
| Market Capitalization | 346.68 M | ||||
| Total Asset | 127.91 M | ||||
| Retained Earnings | (19.15 M) | ||||
| Working Capital | 87.34 M | ||||
| Current Asset | 8.75 M | ||||
| Current Liabilities | 4.68 M | ||||
| Net Asset | 127.91 M |
About Aehr Test Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aehr Test Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aehr Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aehr Test Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aehr Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.Moving against Aehr Stock
| 0.45 | ICHR | Ichor Holdings | PairCorr |
| 0.41 | EHGO | Eshallgo Class A | PairCorr |
| 0.38 | CWAN | Clearwater Analytics | PairCorr |
| 0.36 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Aehr Stock Analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.